Author: Haberer, Th.
Paper Title Page
THPOY025 From Standby Operation to Patient Treatment in 13 Months: Setting Up the MIT Accelerator Team 4146
 
  • A. Peters, Th. Haberer
    HIT, Heidelberg, Germany
  • U. Scheeler
    MIT, Marburg, Germany
 
  When the University Hospital Heidelberg took over the responsibility for the Marburg Ionbeam Therapy Centre (MIT), HIT as their daughter company was mandated to build up the operation team, especially for the accelerator. Based on long-standing experiences of HIT a very similar personnel concept was already available to be adapted to the MIT specialties. Within 9 months the directly started hiring process resulted in three technical teams with excellent engineers and technicians but with little or no accelerator experience. In parallel, three accelerator physicists were appointed for the executive team of MIT. Nevertheless for all hired persons a training program was set up consisting of technical instructions, lectures on fundamental accelerator physics and control system basics. These common trainings were complemented by individual skills development schedules for the tasks in the technical teams. HIT accelerator experts substantially carried out the recommissioning but in addition the new MIT employees were trained in designated shifts in the control room. Thus after only 13 months the MIT operation crew was able to operate the accelerator facility from the first patient treatment day on.  
DOI • reference for this paper ※ DOI:10.18429/JACoW-IPAC2016-THPOY025  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)  
 
TUPOY004 Recommissioning of the Marburg Ion-beam Therapy Centre (MIT) Accelerator Facility 1908
 
  • U. Scheeler, Th. Haberer, C. Krantz, S.T. Sievers, M.M. Strohmeier
    MIT, Marburg, Germany
  • R. Cee, E. Feldmeier, M. Galonska, K. Höppner, J.M. Mosthaf, A. Peters, S. Scheloske, C. Schömers, T.W. Winkelmann
    HIT, Heidelberg, Germany
 
  The Marburg Ion-Beam Therapy Centre (MIT), located in Marburg, Germany, is in clinical operation since 2015. MIT is designed for precision cancer treatment using beams of protons or carbon nuclei, employing the raster scanning technique. The accelerator facility consists of a linac-synchrotron combination, developed by Siemens Healthcare/Danfysik, that was in a state of permanent stand-by upon purchase. With support from its Heidelberg-based sister facility HIT, the MIT operation company (MIT Betriebs GmbH) recommissioned the machine in only 13 months, reaching clinical standards of beam quality delivered to all four beam outlets. With the first medical treatment in October 2015, MIT became the third operational hadron beam therapy centre in Europe offering both proton and carbon beams.  
DOI • reference for this paper ※ DOI:10.18429/JACoW-IPAC2016-TUPOY004  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)